Effect of arteriovenous access closure and timing on kidney function in kidney transplant recipients


Autoři: Seonjeong Jeong aff001;  Hyunwook Kwon aff001;  Jee Yeon Kim aff001;  Young Hoon Kim aff001;  Tae-Won Kwon aff001;  Jung Bok Lee aff002;  Yong-Pil Cho aff001;  Duck Jong Han aff001
Působiště autorů: Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea aff001;  Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea aff002
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
doi: 10.1371/journal.pone.0226309

Souhrn

This study aimed to determine whether the closure of a functioning arteriovenous (AV) access affects the estimated glomerular filtration rate (eGFR) and to compare outcomes according to the timing of AV access closure after kidney transplantation (KT). From 2009 to 2015, medical records were retrospectively reviewed for 142 kidney transplant recipients (KTRs) who underwent AV access closure. The 142 KTRs were categorized into three groups: AV access closure was performed within 6 months after KT in Group 1 (n = 45), at 6–12 months after KT in Group 2 (n = 49), and at 12–24 months after KT in Group 3 (n = 48). The baseline (at the time of AV access closure) and follow-up eGFR values during the 3-year follow-up period were compared. Linear mixed model analysis revealed no significant association between longitudinally observed eGFR values and the amount of time elapsed after AV access closure in the study population (P = 0.36). There was no significant association between 3-year eGFR values and the timing of AV access closure (P = 0.58). In conclusion, after successful KT, AV access closure did not affect the eGFR significantly, and the timing of AV access closure was not significantly associated with outcomes.

Klíčová slova:

Blood pressure – Creatinine – Glomerular filtration rate – Heart failure – Chronic kidney disease – Kidneys – Medical dialysis – Renal transplantation


Zdroje

1. Voorzaat BM, van Schaik J, Siebelink HM, Tordoir JH, Rotmans JI. The pros and cons of preserving a functioning arteriovenous fistula after kidney transplantation. J Vasc Access. 2016;17(Suppl 1):S16–22.

2. Yaffe HC, Greenstein SM. Should functioning AV fistulas be ligated after renal transplantation? J Vasc Access. 2012;13:405–408. doi: 10.5301/jva.5000086 22865530

3. Weekers L, Vanderweckene P, Pottel H, Castanares-Zapatero D, Bonvoisin C, Hamoir E, et al. The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline. Nephrol Dial Transplant. 2017; 32:196–200. doi: 10.1093/ndt/gfw351 27798197

4. Vanderweckene P, Weekers L, Lancellotti P, Jouret F. Controversies in the management of the haemodialysis-related arteriovenous fistula following kidney transplantation. Clin Kidney J. 2018;11:406–412. doi: 10.1093/ckj/sfx113 29992020

5. Vajdič B, Arnol M, Ponikvar R, Kandus A, Buturović-Ponikvar J. Functional status of hemodialysis arteriovenous fistula in kidney transplant recipients as a predictor of allograft function and survival. Transplant Proc. 2010;42:4006–4009. doi: 10.1016/j.transproceed.2010.09.057 21168612

6. Unger P, Wissing KM. Arteriovenous fistula after renal transplantation: utility, futility or threat? Nephrol Dial Transplant. 2006;21:254–257. doi: 10.1093/ndt/gfi276 16293634

7. Kwon H, Kim YH, Choi JY, Sung S, Jung JH, Park SK, et al. Analysis of 4000 kidney transplantations in a single center: Across immunological barriers. Medicine (Baltimore). 2016;95:e4249.

8. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539–2550. doi: 10.1093/eurheartj/ehm037 17428822

9. Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med. 2016;375:1868–1877. doi: 10.1056/NEJMcp1511175 27959663

10. From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol. 2010;55:300–305. doi: 10.1016/j.jacc.2009.12.003 20117433

11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi: 10.7326/0003-4819-150-9-200905050-00006 19414839

12. Reddy YNV, Obokata M, Dean PG, Melenovsky V, Nath KA, Borlaug BA. Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease. Eur Heart J. 2017;38:1913–1923. doi: 10.1093/eurheartj/ehx045 28329100

13. Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant. 2011;26:3296–3302. doi: 10.1093/ndt/gfq851 21317408

14. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, et al. Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant. 2017;32:1330–1337.

15. Locatelli F, Zoccali C. Arteriovenous fistula as a nephroprotective intervention in advanced CKD: scientific discovery and explanation, and the evaluation of interventions. Nephrol Dial Transplant. 2015;30:1939–1941. doi: 10.1093/ndt/gfv281 26232781

16. Golper TA, Hartle PM, Bian A. Arteriovenous fistula creation may slow estimated glomerular filtration rate trajectory. Nephrol Dial Transplant. 2015;30:2014–2018. doi: 10.1093/ndt/gfv082 25888388

17. Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, et al. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet. 2015;385:1634–1641. doi: 10.1016/S0140-6736(14)62053-5 25620016

18. Burchell AE, Lobo MD, Sulke N, Sobotka PA, Paton JF. Arteriovenous anastomosis: is this the way to control hypertension? Hypertension. 2014;64:6–12. doi: 10.1161/HYPERTENSIONAHA.114.02925 24711522

19. Korsheed S, Crowley LE, Fluck RJ, McIntyre CW. Creation of an arteriovenous fistula is associated with significant acute local and systemic changes in microvascular function. Nephron Clin Pract. 2013;123:173–179. doi: 10.1159/000353708 23921165

20. Dundon BK, Torpey DK, Nelson AJ, Wong DT, Duncan RF, Meredith IT, et al. Beneficial cardiovascular remodeling following arterio-venous fistula ligation post-renal transplantation: a longitudinal magnetic resonance imaging study. Clin Transplant. 2014;28:916–925. doi: 10.1111/ctr.12402 24931318

21. Letachowicz K, Królicki T, Bardowska K, Drabik A, Zajdel K, Kamińska D, et al. The impact of functioning arteriovenous fistula on blood pressure control and renal allograft function. Transplant Proc. 2018;50:1855–1857. doi: 10.1016/j.transproceed.2018.03.109 30056915

22. Unger P, Xhaët O, Wissing KM, Najem B, Dehon P, van de Borne P. Arteriovenous fistula closure after renal transplantation: a prospective study with 24-hour ambulatory blood pressure monitoring. Transplantation. 2008;85:482–485. doi: 10.1097/TP.0b013e318160f163 18301341

23. Unger P, Wissing KM, de Pauw L, Neubauer J, van de Borne P. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation. 2002;74:73–79. doi: 10.1097/00007890-200207150-00013 12134102

24. van Duijnhoven EC, Cheriex EC, Tordoir JH, Kooman JP, van Hooff JP. Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant. 2001;16:368–372. doi: 10.1093/ndt/16.2.368 11158414

25. De Lima JJ, Vieira ML, Molnar LJ, Medeiros CJ, Ianhez LE, Krieger EM. Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft. Cardiology. 1999;92:236–239. doi: 10.1159/000006980 10844383

26. Peteiro J, Alvarez N, Calviño R, Penas M, Ribera F, Castro Beiras A. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study. Cardiology. 1994;85:273–283. doi: 10.1159/000176695 7850816

27. Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, et al. Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients. Circulation. 2019;139:2809–2818. doi: 10.1161/CIRCULATIONAHA.118.038505 31045455

28. Einollahi B, Sadeghi Ghahrodi M. Hemodialysis arteriovenous fistula after transplant: to keep or not to keep? Iran J Kidney Dis. 2012;6:159–161. 22555474

29. Laranjinha I, Matias P, Oliveira R, Casqueiro A, Bento MT, Carvalho AP, et al. The impact of functioning hemodialysis arteriovenous accesses on renal graft perfusion: Results of a pilot study. J Vasc Access. 2019;20:482–487. doi: 10.1177/1129729818817248 30520327


Článek vyšel v časopise

PLOS One


2019 Číslo 12